Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 72%
filed 2026-09-29
EX-99.1
The exhibit announces that Chairman and CEO Jonathan Chiang will relocate full-time to the United States to lead growth initiatives and U.S. operations. While this involves a senior executive's relocation and operational focus shift, it does not constitute a departure (he remains in role), appointment (no new person is taking a position), or compensation change. The disclosure is material because it signals a strategic pivot in leadership presence and operational focus toward U.S. expansion in aerospace, defense, and higher-value composite markets, which would affect investor assessment of the company's growth trajectory and capital allocation strategy.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-29
EX-99.3
This is a press release announcing unaudited financial results for the six months ended June 30, 2026. The document discloses revenue ($11.9M vs. $17.6M prior year), gross margin expansion (270 basis points to 12.8%), operating loss improvement (46.8% to $2.2M), and net loss improvement (46.7% to $2.5M). The company explicitly states it "announced unaudited financial results for the six months ended June 30, 2026," making this a discrete earnings release event, not the periodic report itself.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-09-29
EX-99.1
JBDI Holdings Ltd is soliciting shareholder votes on four governance proposals at an Extraordinary General Meeting scheduled for October 22, 2026: increasing authorized share capital from 500M to 5B shares, creating a dual-class share structure with Class B super-voting shares (100 votes per share), adopting amended memorandum and articles of association, and issuing 7M Class B shares to controlling shareholder EUG INVESTMENT LIMITED. The creation of super-voting Class B shares concentrated in the controlling shareholder materially affects voting power and governance structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
EX-99.1
This press release announces WeShop's U.S. market launch on November 16, 2026, following a successful UK pilot that generated £108.5M in GMV. The launch is a material operational and strategic milestone—the company is entering a major new market (the U.S.) with its community-owned shopping platform and ShareBack rewards program. While not a discrete M&A transaction, earnings release, or governance event, this represents a significant business expansion that would affect a reasonable investor's assessment of the company's growth trajectory and market opportunity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-29
Atlas Critical Minerals engaged SGS Canada Inc. to prepare a technical report summary with a maiden resource estimate for its Malacacheta Graphite Project in Brazil, filed as Exhibit 96.1. This is a material operational milestone — the first formal resource estimate for a mineral project — that would affect a reasonable investor's assessment of the company's asset base and development prospects, but does not fit a discrete event category (not M&A, not a financial result, not a governance change). Classified as operational_other because the domain is clearly operational/strategic, but the specific event type (resource estimate disclosure) does not match any named category.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-29
The 8-K discloses fiscal 2026 financial results via a press release (Exhibit 99.1) dated September 29, 2026, reporting annual results for the year ended June 30, 2026. The filing presents comprehensive financial metrics including total revenues ($73.951M, +15% YoY), income from operations (+55%), and a return to GAAP net income ($0.336M) after a prior-year loss, along with segment-level performance across Hotel Operations, Real Estate Operations, and Investment Transactions. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-29
The 8-K discloses Portsmouth Square's fiscal 2026 financial results via a press release dated September 29, 2026. The filing reports hotel revenues increased 20% year-over-year to $55.797 million, operating income more than doubled to $7.789 million, and GAAP net loss improved by $3.696 million. This is a standard earnings release disclosure for a fiscal year-end, material to investors assessing the company's financial performance and recovery trajectory.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-29
The filing discloses the resignation of the entire Board of Directors (Jeremy Rosenthal on September 8, followed by Michael Dunn, Travis Washko, Mark Carrington, Michael Freed, and Vincent Puccio on September 11, leaving the Company with no remaining board members) and the resignation of both the Chief Executive Officer (Ray Liang, effective September 30) and Chief Financial Officer (Tan Yee Siong, effective September 30). This represents a complete departure of executive leadership and governance, which is material to any reasonable investor's assessment of the registrant's ability to operate and maintain corporate governance.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-29
EX-99.1
The exhibit announces the closing of an underwriter's over-allotment option exercise, resulting in the sale of 648,373 Class A ordinary shares at $1.15 per share for approximately $745,629 in gross proceeds. This is a dilutive equity issuance in connection with a public offering (Form F-1), bringing total offering proceeds to approximately $5.7 million. The company explicitly states it is raising capital through registered public equity issuance, which is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-29
Jeffrey Shuman notified the Board on September 28, 2026 that he was retiring from the Board of Directors. This is a clear departure of a director from the registrant. The filing explicitly states his retirement was not related to any disagreement, but the core event is a director leaving the company, which is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-09-29
The filing discloses multiple material events, but the most salient Item 5.02 disclosure centers on compensatory arrangements: the Company issued 200,000 shares of Series A Convertible Preferred Stock to CEO David Boulette pursuant to an Executive Employment Agreement entered into on August 17, 2026. While the filing also includes governance amendments (Item 5.03), the Item 5.02 compensation grant is the primary executive action reported and would materially affect investor assessment of executive incentives and capital structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-29
The filing discloses receipt of a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, with potential for a five-year program covering approximately 2,500 sites and up to $60 million in revenue. This is a material operational/commercial milestone—a significant customer order and business development event—but does not fit the specific categories of earnings release, M&A activity, or other named event types. The disclosure is made under Item 7.01 (Regulation FD Disclosure) via press release, indicating a material business development that would affect investor assessment of the company's growth prospects and market traction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-29
The 8-K discloses financial results for fiscal year ended June 30, 2026 under Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The press release announces record fiscal 2026 results including 24.8% revenue growth to $80.1 million, 21.3% net income growth to $9.1 million, and 11.9% diluted EPS growth to $0.66, along with operational highlights such as 9% enrollment growth and geographic expansion. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-29
Mark Hamm, Chief Operating Officer and Board member of Arrive AI Inc., notified the Company of his resignation effective October 2, 2026. The filing discloses under Item 5.02 that this departure was not the result of any disagreement with the Company. The resignation of a C-suite executive (COO) and director is a material event affecting the registrant's leadership structure and operational continuity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
The filing discloses a strategic business combination transaction between Bunker Hill Mining Corp. and Silver47 Exploration Corp. pursuant to a statutory plan of arrangement. The company has commenced mailing a proxy statement to stockholders regarding a special meeting to approve the Arrangement, which constitutes material M&A activity requiring shareholder approval under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
FingerMotion entered into a definitive Share Purchase Agreement on September 23, 2026 to acquire 100% of Newbit Technology Inc. for US$2.3 million in cash. The acquisition includes material assets—a 9.9 MW behind-the-meter power site in Alberta with surface leases, permits, pipeline infrastructure, and environmental approvals. Item 1.01 explicitly discloses this as "Entry Into a Material Definitive Agreement," and the transaction is clearly material to investors as it represents a significant capital deployment and strategic asset acquisition for the company's power and compute program.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
The filing discloses completion of two material acquisitions on September 29, 2026: (1) acquisition of 60% of Xing Da Plastics Sdn. Bhd. for 4.8 million shares, and (2) acquisition of 100% of Invent Fortune Sdn. Bhd. for approximately 36.5 million shares. Item 2.01 explicitly states "Completion of Acquisition or Disposition of Assets," and Item 3.02 discloses the unregistered issuance of equity as consideration, indicating a material change of control transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-29
The filing discloses Item 5.07 results from Bone Biologics' Annual Meeting of stockholders held on September 28, 2026, including voting outcomes on six proposals: director elections (Stroever, Angle, Gagnon, Meikle), advisory compensation approval, auditor ratification (Weinberg & Company), warrant issuance authorization under Nasdaq Rule 5635(d), reverse stock split authorization (1-for-2 to 1-for-10), and meeting adjournment. All proposals passed. This is a material shareholder vote disclosure affecting investor understanding of governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
The filing discloses the appointment of Ross Tannenbaum as Chief Executive Officer of NextBoat Inc., effective September 28, 2026, following Board approval on September 25, 2026. While the filing also mentions the concurrent resignation of prior CEO Brian S. John, the principal disclosed action centers on Tannenbaum's appointment to the CEO role. The filing provides extensive detail on his background, compensation arrangements (including 2.5 million stock options), and employment terms, all consistent with a material executive appointment. This is a C-suite leadership change material to investors.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-09-29
The filing discloses under Item 4.01 the dismissal of Turner Stone & Company, LLP as the independent registered public accounting firm effective September 24, 2026, and the simultaneous appointment of CBIZ CPAs P.C. as the new auditor. While the prior auditor's report included an explanatory paragraph regarding substantial doubt about going concern, the primary disclosed event is the auditor change itself. This is material to investors as it affects the registrant's financial reporting oversight and audit independence.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
The filing discloses the appointment of Naveen Jain to Celularity's Board of Directors effective upon completion of the Rule 14f-1 information statement process. This is a material board appointment of a prominent entrepreneur and CEO with significant experience in technology and health sectors. The appointment was designated by investors in connection with the Company's September 2026 financing, and is accompanied by the resignation of director Diane Parks, making this a significant governance event.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-29
The filing discloses a 1-for-10 reverse stock split of TruGolf's common stock, effective September 29, 2026, filed pursuant to Item 5.03 (Amendments to Articles of Incorporation or Bylaws). While a reverse split is a capital structure modification rather than a traditional governance event, it materially affects security holders' rights and the company's authorized share structure, making it a governance-related disclosure that does not fit the specific named categories (exec appointment/departure, compensation, shareholder vote results, etc.). The reverse split reduces authorized shares from 101 million to 10.1 million and outstanding shares from ~12.44 million to ~1.24 million, with cash payment for fractional shares.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-09-29
The filing discloses a corporate name change from "AIxCrypto Holdings, Inc." to "FF EAI Robotics Ecosystem Inc." approved by the board on September 23, 2026, effective September 30, 2026, along with corresponding bylaws amendments and a trading symbol change from AIXC to FFR. While Item 5.03 governs amendments to articles and bylaws, the substance here is a material governance event—a name change signaling a strategic pivot to robotics operations and a proposed acquisition of Faraday Future's robotics business. The filing also references an investor presentation disclosing the company's transition strategy and the proposed FFAI robotics acquisition, which is material to investors assessing the registrant's direction, though the acquisition itself is not yet definitive. This is primarily a governance/strategic disclosure rather than a specific M&A completion.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
Item 8.01
Item 8.01 discloses the completion of a business combination between Hennessy Capital Investment Corp. VII (HVII) and ONE Nuclear Energy LLC, resulting in ONE Nuclear Energy Inc. as the successor issuer. The filing reports the domestication and business combination with aggregate consideration of $1.0 billion to existing equityholders, evidenced by multiple amendments to the Business Combination Agreement dated October 22, 2025 through August 7, 2026, culminating in the September 23, 2026 domestication. This is a material acquisition/change of control transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
The filing discloses the completion of a material asset disposition on September 23, 2026, whereby Altruis Benefit Consultants, Inc. (a wholly owned subsidiary of Reliance Global Group) sold substantially all assets of its employee benefits insurance agency business to Altruis Benefit Management, LLC for $8,000,000 in cash, promissory note, and contingent earnout payments. Items 1.01 and 2.01 explicitly document entry into and completion of this material definitive agreement and asset disposition, which would materially affect a reasonable investor's assessment of the registrant's operations and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-29
The filing discloses results of a Special Meeting held on September 24, 2026, where stockholders voted on three proposals: (1) an Extension Proposal to extend the business combination deadline from September 28, 2026 to March 28, 2027; (2) a Trust Amendment Proposal to amend the Investment Management Trust Agreement; and (3) an Adjournment Proposal. All three proposals were approved with overwhelming support (3,437,439 votes FOR, 4,523 AGAINST, 2,500 ABSTAINED). Item 5.07 explicitly governs submission of matters to a vote of security holders, and the filing presents detailed voting tallies and outcomes. This is material to investors as it determines the company's continued existence as a SPAC and extends its timeline to complete a business combination.
View raw filing on EDGAR →
6-K
Auditor Change
confidence 96%
filed 2026-09-29
EX-99.1
Zeifmans LLP resigned as auditor effective September 29, 2026, and PricewaterhouseCoopers LLP was appointed as successor auditor on the same date. The change was disclosed pursuant to National Instrument 51-102 Section 4.11, with no modified opinions or reportable events noted.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-29
Item 8.01
Xylem completed a public offering of $1.5 billion in aggregate principal amount of senior notes across three series (2029, 2032, and 2037 maturities) on September 29, 2026. This is a material creation of direct financial obligations governed by an indenture. The company explicitly states it intends to use net proceeds to finance the Cornell Pump and Roper Pump acquisition and for general corporate purposes, making this a significant capital-raising event that would affect investor assessment of the registrant's financial position and leverage.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-29
Item 3.02
The filing discloses unregistered issuances of common stock totaling approximately 918,114 shares (pre-split) in exchange for preferred stock held by existing shareholders, relying on Section 3(a)(9) of the Securities Act. These exchanges are dilutive to existing common shareholders and represent material capital transactions, particularly the September 23 issuances to unaffiliated investors and Stilwell Investors (a related party through board member Joseph Stilwell). The Item 3.02 disclosure and the magnitude of shares issued (21,022 post-split from the September 8 transaction alone) confirm materiality.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-09-29
Item 2.03
Bloomin' Brands amended and restated its $1.2 billion revolving credit facility on September 25, 2026, extending the maturity date to September 25, 2031 and adding a new senior secured net leverage ratio covenant. This material modification of the company's debt structure strengthens its capital structure and enhances financial flexibility.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-09-29
Item 8.01
News Corporation disclosed daily buy-back notifications to the ASX under its $1 billion repurchase program authorized July 15, 2025. The Item 8.01 disclosure reports that the company purchased approximately 12.6 million Class A shares and 62,323 Class B shares on September 29, 2026, with total consideration of approximately $330.5 million to date under the program. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution taxonomy as a return of capital program, distinct from a one-time dividend but materially affecting shareholder value.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
Item 1.01
The filing discloses entry into a material definitive agreement for the sale of the Four Seasons Resort Scottsdale at Troon North for $372 million, with a non-refundable $10 million deposit received. This is a disposition of a material asset by the Company's indirect subsidiaries, fitting squarely within Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type. The transaction value and nature of the asset (a resort property) make it material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-29
Item 5.02
Terry L. Nutt was appointed as CEO and President effective January 1, 2027, with board membership to follow. The appointment includes a detailed employment agreement with $1.2M base salary, 135% target bonus, and 700% long-term incentive compensation. Mark McFarland transitioned from CEO to Senior Advisor role as part of the succession.
View raw filing on EDGAR →
8-K
Financial Other
confidence 65%
filed 2026-09-29
Item 8.01
Talen Energy executed a capacity monetization transaction generating approximately $1.5 billion in proceeds through the sale of future PJM capacity revenues, and concurrently announced a $1.5 billion share repurchase program upsizing with accelerated share repurchase agreements. These transactions represent material capital allocation and financial restructuring activities.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-29
Item 8.01
PNC announced the redemption of $525 million in Depositary Shares representing interests in Series S Preferred Stock on November 2, 2026, at $1,000 per share. While redemption of preferred stock is technically a return of capital to preferred shareholders, the disclosure emphasizes the redemption price and any unpaid dividends to be paid on the redemption date, which aligns with the dividend_distribution category as a material distribution to security holders. The $525 million redemption amount is material to a large financial institution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-29
Item 1.01
Creatd entered into a Share Exchange Agreement on September 23, 2026, acquiring a 10% equity stake in C2 Capital Group (C2 Live) for 300,000 shares of common stock and 25,064 shares of Series B Convertible Preferred Stock, with a non-binding letter of intent to acquire the remaining 90%. The transaction is valued at approximately $3.6 million and is expected to increase stockholders' equity from $5 million to $8 million.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-29
Item 1.01
Advanced Flower Capital Inc. entered into Amendment Number Ten to its Loan and Security Agreement on September 25, 2026, materially modifying the credit facility by increasing aggregate revolver commitments to $130 million (including a $50 million quarterly temporary increase) and revising the loan fee structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-29
Item 5.07
The Company held its annual meeting of stockholders on September 29, 2026, and disclosed voting results for the election of seven directors and ratification of Deloitte & Touche as independent auditor, with detailed vote tallies for each proposal.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-29
Item 1.01
Tesla entered into three new credit facilities totaling $30 billion in committed borrowing capacity—a $20 billion delayed draw term loan, an $8 billion five-year revolving facility, and a $2 billion 364-day revolving facility—and terminated a $5.0 billion revolving credit facility dated January 20, 2023. This refinancing activity represents a material creation of new direct financial obligations affecting Tesla's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-29
Item 2.03
On September 23, 2026, Vulcan Infrastructure & Power Inc. entered into an exchange agreement whereby it issued $2,833,358 in principal of new 2030 Notes and 1,000,000 warrant shares in exchange for $2,793,150 of existing 2026 Notes, materially restructuring its debt obligations and extending maturity while introducing dilutive warrant issuance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-29
Item 5.02
James L. L. Tullis, the Board's Lead Independent Director, tendered his resignation from the Board effective at the conclusion of the 2027 Annual Meeting of Stockholders. This is a departure of a director from the Board, driven by the Company's retirement policy for directors. The resignation of a Lead Independent Director is material to investors as it affects board composition and governance structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-29
Item 5.07
This Item 5.07 disclosure reports the results of the Annual Meeting of Shareholders held on September 24, 2026, including voting outcomes on three proposals: election of directors (with detailed vote tallies for Class A and Class B shareholders), ratification of PricewaterhouseCoopers LLP as independent auditors, and an advisory vote on named executive officer compensation. The filing directly matches the shareholder_vote_results event type, which covers results of votes at annual or special meetings of security holders.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-29
Item 8.01
The Board of Directors authorized an additional $1.0 billion in share repurchases under the Company's existing repurchase program on September 25, 2026, bringing the aggregate authorized amount to $2.0 billion. This authorization signals management's confidence in the stock and affects capital allocation strategy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
EX-99
The announcement discloses FDA Fast Track designation for Telix's BiPASS program, a clinical development milestone for a proprietary 68Ga-PSMA-PET imaging program in pre-biopsy prostate cancer diagnosis. Fast Track status facilitates more frequent FDA engagement and may enable expedited review of the planned NDA, representing a material regulatory advancement that would affect investor assessment of the company's development timeline and commercial prospects. This is an operational/regulatory milestone rather than a discrete event type (not an earnings release, M&A activity, executive change, or financial obligation).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-29
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on September 24, 2026. The filing reports voting outcomes on five proposals: election of six directors, approval of an equity incentive plan amendment, advisory vote on executive compensation, ratification of auditors (BDO USA, P.C.), and adjournment authority. All proposals passed with majority support, making this a material governance event that affects investor understanding of board composition and capital allocation authority.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-29
Item 5.02
Kevin Christy was elected as a director representing NRPPD on Tri-State's Board of Directors, effective September 28, 2026. This is a clear appointment of a director to the board, which is a material governance event affecting the composition of the registrant's leadership and board oversight.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-29
EX-99.1
This press release announces AstraZeneca's submission of a US NDA for ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) for MET-driven EGFR-mutated lung cancer, supported by positive Phase III SAFFRON trial results showing statistically significant improvements in progression-free and overall survival. This is a material regulatory milestone and product development event for HUTCHMED's co-developed therapeutic, but does not fit the discrete event categories (not an earnings release, M&A activity, executive change, or financial obligation). It represents a significant operational/strategic advancement in the clinical development and regulatory pathway for a key pipeline asset.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-29
Item 5.02
The filing discloses revised employment agreements for two named executives—Robin L. Oliver (EVP and COO) and Scott J. McKim (EVP, CFO, and principal financial officer)—entered into on September 24, 2026. The agreements specify minimum annual salaries ($350,000 and $325,000 respectively), eligibility for employee benefit plans, stock grants, cash incentive payments, severance arrangements (200% of base salary plus average bonus upon change of control), and post-termination non-solicitation covenants. This is a compensatory arrangement disclosure under Item 5.02(e), material to investors assessing executive retention and change-of-control protections.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-09-29
AstraZeneca announces a $2 billion equity investment in Summit Therapeutics Inc., acquiring approximately 12.0% of Summit's outstanding common stock (10.6% fully diluted). This constitutes a material acquisition of a significant equity stake coupled with a strategic clinical collaboration agreement to develop and commercialize ivonescimab in combination with AstraZeneca's ADC portfolio across multiple cancer indications. The investment and collaboration represent a material change of control interest and strategic transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-29
Item 2.02
This is a clear earnings release disclosing Luvu Brands' fiscal 2026 financial results for the year ended June 30, 2026. The press release (Exhibit 99.1) announces key metrics including 5.8% revenue growth to $27.36 million, gross margin expansion to 31.5%, return to operating profitability with $876,000 operating income, and Adjusted EBITDA tripling to $1.26 million. The filing includes complete consolidated financial statements (income statement, balance sheet, and cash flow statement) and is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.
View raw filing on EDGAR →